by Mark Chiang
馬克·蔣
Share To
分享到
Novo Nordisk has announced the appointment of Maziar Mike Doustdar as its new Chief Executive Officer and President. Doustdar, who currently serves as the company’s head of international operations, will assume his new role following a leadership transition. The decision marks a significant development for the global pharmaceutical company, which is known for its focus on diabetes care and other chronic diseases..
諾和諾德宣佈任命馬齊亞爾·邁克·杜斯塔爾爲新任首席執行官兼總裁。杜斯塔爾目前擔任公司國際業務負責人，他將在領導層過渡後履新。這一決定標誌着這家以糖尿病護理和其他慢性疾病爲重點的全球製藥公司迎來了重大發展。
The announcement comes as Novo Nordisk continues to expand its presence in international markets under Doustdar’s leadership in his current position. His tenure overseeing international operations has been marked by efforts to strengthen the company’s footprint outside of Denmark, where it is headquartered.
該公告發布之際，諾和諾德在道斯特達爾現任職位的領導下，繼續擴大其在國際市場的影響力。他在監管國際業務期間，一直致力於加強公司在總部丹麥以外的市場地位。
The company did not provide further details about the timeline for Doustdar’s transition into the CEO role or any additional changes to its executive team at this time..
該公司沒有提供關於道斯坦達爾過渡到首席執行官角色的時間表或其高層管理團隊的任何其他變動的更多細節。
Newsflash | Powered by GeneOnline AI
新聞快訊 | 由GeneOnline AI提供支持
Source: GO-AI-ne1
來源：GO-AI-ne1
Date: July 29, 2025
日期：2025年7月29日
Related posts:
相關文章：
DrugPatentWatch Recommends 7 Key Elements for CDMO Contracts to Ensure Successful Collaboration
DrugPatentWatch 推薦 CDMO 合同的 7 個關鍵要素以確保成功合作
Researchers Utilize Nine Molecular Methods to Analyze Tumors and Guide Personalized Cancer Treatment
研究人員利用九種分子方法分析腫瘤並指導個性化癌症治療
Drug Channels Institute Launches Six eLearning Modules Focused on Pharmaceutical Economics
藥品渠道研究所推出六個專注於藥物經濟學的電子學習模塊
Key Protein Identified as Potential Target for Developing Acute Myeloid Leukemia Therapies
關鍵蛋白質被確定爲開發急性髓系白血病療法的潛在靶點
©www.geneonline.com All rights reserved. Collaborate with us:
©www.geneonline.com 版權所有。與我們合作：
[email protected]
[email protected]
Author
作者
Mark Chiang
馬克·江
Related Post
相關文章
News Flash
新聞快訊
White House Meeting Addresses AI Challenges in Medicaid Eligibility Verification
白宮會議探討醫療補助資格驗證中的人工智能挑戰
2025-07-29
2025年7月29日